Dr. David A. Bond, MD

Claim this profile

Ohio State University Comprehensive Cancer Center

Studies Diffuse Large B-Cell Lymphoma
Studies Lymphoma
3 reported clinical trials
8 drugs studied

Area of expertise

1

Diffuse Large B-Cell Lymphoma

David A. Bond, MD has run 3 trials for Diffuse Large B-Cell Lymphoma. Some of their research focus areas include:

MYC positive
BCL6 positive
BCL2 positive
2

Lymphoma

David A. Bond, MD has run 3 trials for Lymphoma. Some of their research focus areas include:

MYC positive
BCL6 positive
BCL2 positive

Affiliated Hospitals

Image of trial facility.

Ohio State University Comprehensive Cancer Center

Image of trial facility.

The Ohio State University James Cancer Hospital

Clinical Trials David A. Bond, MD is currently running

More about David A. Bond, MD

Clinical Trial Related

2 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments David A. Bond, MD has experience with

  • Carboplatin
  • Etoposide
  • Ifosfamide
  • Lenalidomide
  • Tafasitamab
  • DA-REPOCH Chemotherapy Regimen

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does David A. Bond, MD specialize in?

Is David A. Bond, MD currently recruiting for clinical trials?

Are there any treatments that David A. Bond, MD has studied deeply?

What is the best way to schedule an appointment with David A. Bond, MD?

What is the office address of David A. Bond, MD?

Is there any support for travel costs?